Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03551873 · ClinicalTrials.gov registry record
A Postmarketing Study of Plecanatide in Breast Milk of Lactating Women Treated With TRULANCE®
A clinical trial, sponsored by Bausch Health Americas.
- Completed
- Registry status
- 7
- Enrollment target
NCT03551873 is a clinical trial that has completed, run by Bausch Health Americas. The registered enrollment target is 7 participants.
The verdict
NCT03551873 has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
This is a multi-center, open-label study evaluating pharmacokinetics of TRULANCE® (plecanatide) in breast milk of lactating women treated with TRULANCE
Interventions
- DRUG Plecanatide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2018-06-21 |
| Est. Completion | 2018-12-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03551873
The ClinicalTrials.gov registry entry for NCT03551873 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Plecanatide is the first listed.
NCT03551873 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03551873 about?
NCT03551873 is a clinical study titled "A Postmarketing Study of Plecanatide in Breast Milk of Lactating Women Treated With TRULANCE®". This is a multi-center, open-label study evaluating pharmacokinetics of TRULANCE® (plecanatide) in breast milk of lactating women treated with TRULANCE
What is the current status of trial NCT03551873?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2018-06-21. Estimated completion is 2018-12-14.
What interventions are being tested in trial NCT03551873?
The interventions under investigation include: Plecanatide (DRUG).
Who is sponsoring clinical trial NCT03551873?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.